Molecular analysis of gene mutations that are connected with an increased risk of developing certaindiseases (i.e. hereditary cancers, heart diseases). Such tests include the BRCA1 and BRCA2 genes for families with breast and ovary cancer history, the APC gene for Familial Adenomatous Polyposis and families with colorectal cancer history and the genes RET and MEN1 with families with multiple endocrine neoplasia syndromes.

Next Generation Sequencing (NGS) analysis of 30 genes involved in the development of hereditary tumors and cancer of breast, ovaries, uterus, intestines, stomach, pancreas, melanoma and prostate. The 30 genes analyzed with the Cancer Risk Test are: BRCA1, BRCA2, APC, ATM, BAP1, BARD1, BMPR1A, BRIP1, CDH1, CDKN2A CDK4, CHEK2, EpCAM, GREM1, MLH1, MSH2, MSH6, MITF, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11 and TP53